Insider Transactions in Q3 2023 at Sigilon Therapeutics, Inc. (SGTX)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 11
2023
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
797,720
-100.0%
|
$11,168,080
$14.92 P/Share
|
Aug 11
2023
|
Lilly & CO Eli > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,718,493
+99.99%
|
$24,058,902
$14.92 P/Share
|
Aug 11
2023
|
Josias Pontes CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,504
-100.0%
|
-
|
Aug 11
2023
|
Coelho Rogerio Vivaldi PRESIDENT AND CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,169
-100.0%
|
-
|
Aug 11
2023
|
Qing Sarah Yuan CTOO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,884
-100.0%
|
-
|
Aug 11
2023
|
Matthew Paul Kowalsky CHIEF OF STAFF AND CLO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,925
-100.0%
|
-
|
Aug 11
2023
|
John Cox |
SELL
Sale (or disposition) back to the issuer
|
Direct |
341
-100.0%
|
-
|
Jul 27
2023
|
Qing Sarah Yuan CTOO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,884
+50.0%
|
$54,796
$19.24 P/Share
|
Jul 21
2023
|
Coelho Rogerio Vivaldi PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,528
+31.6%
|
$105,032
$19.24 P/Share
|
Jul 21
2023
|
Josias Pontes CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,444
+30.74%
|
$27,436
$19.24 P/Share
|